Work

Abstract P4-21-40: In vitro and in vivo activity of HER2-targeted antibody-liposomal doxorubicin conjugate MM-302 in HER2-intermediate tumors

Year: 2017

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.sabcs16-p4-21-40

Authors: E Geretti, C Espelin, B Adiwijaya, S Coma, Z Koncki, P Sumner, N Dumont, G Garcia, T Bloom, J Janovsky, J Reynolds, K Campbell, V Moyo, I Molnar, P LoRusso, I Krop, K Miller, C Ma, P Munster, T Wickham

Institutions: Washington University in St. Louis, Yale Cancer Center, Yale University, Dana-Farber Cancer Institute, Merrimack Pharmaceuticals (United States), UCSF Helen Diller Family Comprehensive Cancer Center, Indiana University Melvin and Bren Simon Comprehensive Cancer Center

Language: English

Topic: HER2/EGFR in Cancer Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2944007606

Cites:

Cited by:

Related to: 10